LivaNova PLC EBIT

LivaNova PLC (LIVN) currently reports a EBIT of $170M as of March 2026. That compares with $-190M in the prior-year period — up 186.0% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore LivaNova PLC's EBIT history and peer comparisons.

LivaNova PLC's EBIT increased from $-190M to $170M — a 186.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LivaNova PLC's EBIT of $170M is lower than the Healthcare sector average of $23B. That is roughly 99.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

LivaNova PLC reported $170M in EBIT as of March 2026. That compares with $-190M in the prior-year period — up 186.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for LivaNova PLC, and consider following LIVN for alerts when major investors trade the stock.